Role of Irbesartan in Prevention of Post-Coronary Artery Bypass Graft Atrial Fibrillation

Author： El-Haddad Mohamed A. Zalawadiya Sandip K.

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.11, Iss.4, 2011-08, pp. : 277-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Post–Coronary Artery Bypass Grafting (CABG) Atrial Fibrillation: Efficacy of Prophylactic Beta-Blockers in the Modern Era

By Khan Muhammad Fahad Wendel Christopher S. Movahed Mohammad Reza

Annals of Noninvasive Electrocardiology, Vol. 18, Iss. 1, 2013-01 ,pp. : 58-68

Blackwell Publishing

Access to resources Recommend Favorite

Morbidity of Post-Coronary Artery Bypass Surgery Patients with Atrial Fibrillation Treated with Rate Control versus Sinus-Restoring Therapy

Heart Drug, Vol. 1, Iss. 4, 2001-10 ,pp. : 192-196

Karger

Access to resources Recommend Favorite

Managing atrial fibrillation after coronary artery bypass graft surgery involves prophylaxis, cardioversion and/or ventricular rate control

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 22, Iss. 9, 2006-09 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety

By Kulik Alexander Ruel Marc

Expert Opinion on Drug Safety, Vol. 8, Iss. 5, 2009-09 ,pp. : 559-571

Informa Healthcare

Access to resources Recommend Favorite

Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia?

By Sur Swastika Sugimoto Jeffrey T. Agrawal Devendra K.

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 7, 2014-01 ,pp. : 531-545

NRC Research Press

Access to resources Recommend Favorite